Furthermore, genetic deletion or pharmacologic inhibition of CaMK4 ameliorates Th17 cell-mediated autoimmune diseases, such as experimental autoimmune encephalomyelitis (EAE) and lupus-like disease in mice24–26. Here, CAMK4 is linked to autoimmune disease.